The progressive loss of skeletal muscle mass and concomitant reduction in contractile
strength plays a central role in frailty syndrome. Age-related neuronal impairments are …

Sarcopenia is a prevalent degenerative skeletal muscle condition in the elderly population,
posing a tremendous burden on diseased individuals and healthcare systems worldwide …

Sarcopenia is a skeletal muscle disorder characterized by progressive and generalized
decline in muscle mass and function. Although it is mostly known as an age-related disorder …

Promoting the efficiency of bone regeneration in bone loss diseases is a significant clinical
challenge. Traditional therapies often fail to achieve better therapeutic outcomes and shorter …

Background The aging of skeletal muscle is the leading cause of physical disability in older
adults, currently effective treatment methods are lacking. Ginsenoside Rh4, an active …

The treatment of bone defects is still an intractable clinical problem, despite the fact that
numerous treatments are currently available. In recent decades, bone engineering scaffolds …

Since sarcopenia is a progressive condition that leads to decreased muscle mass and
function, especially in elderly people, it is a public health problem that requires attention …

The skeletal muscle (SM) is the largest organ in the body and has tremendous regenerative
power due to its myogenic stem cell population. Myostatin (MSTN), a protein produced by …

When skeletal and cardiac tissues are damaged, surgical approaches are not always
successful and tissue regeneration approaches are investigated. Reports in the literature …

Background Genetic substrate reduction therapy (gSRT), which involves the use of nucleic
acids to downregulate the genes involved in the biosynthesis of storage substances, has …